Rebates rapidly approach $5 billion as PBS growth hits double digits

According to the health department's annual report, companies paid almost $4.7 billion in rebates for PBS-listed medicines in 2022-23, while growth in spending on the program with a larger than-expected accrual was 13 per cent. …